BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Cisplatin
,
rs2300478
,
VEGFA
,
Response to oxidative stress
,
Allergy to pollen
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
sphingomyelin phosphodiesterase activator activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Microglial cell
B lymphocyte (IgM memory) of spleen
Testes
Fetal brain
Eosinophil of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Multiple-resistant Staphylococcus aureus infection
Methicillin resistant Staphylococcus aureus infection
Disease caused by rickettsiae
Tularemia
Disease due to Papilloma virus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
ursocholic acid
Recombinant Fusion Proteins
Vecuronium Bromide
Coumarins
F8 protein, human
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
DUXB
HR
CLIC4
RPS6
NOL4L
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Adipose MSC ASC52telo cells with shRNA-mediated gene knockdown
L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for sphingomyelin phosphodiesterase activator activity
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Tra…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ